Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China
· Delayed Price · Currency is CNY 31.70
-0.41 (-1.28%)
Apr 3, 2025, 3:00 PM CST
SHA:603882 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Net Income | 161.2 | 643.38 | 2,755 | 2,220 | 1,510 | 402.33 | Upgrade
|
Depreciation & Amortization | 563.61 | 563.61 | 528.4 | 425.98 | 280.85 | 256.55 | Upgrade
|
Other Amortization | 114.96 | 114.96 | 90.46 | 107.99 | 67.79 | 53.35 | Upgrade
|
Loss (Gain) From Sale of Assets | -2.2 | -2.2 | -3.99 | 9.74 | -2.11 | 0.01 | Upgrade
|
Asset Writedown & Restructuring Costs | 9.77 | 9.77 | 1.02 | 0.37 | 0.67 | 0.15 | Upgrade
|
Loss (Gain) From Sale of Investments | -262.97 | -262.97 | 10.8 | 7.29 | 18.66 | -40.01 | Upgrade
|
Provision & Write-off of Bad Debts | 488.41 | 488.41 | 255.31 | 71.09 | 46.93 | 24.38 | Upgrade
|
Other Operating Activities | 300.41 | 14.13 | 105.32 | 172.8 | 93.36 | 49.71 | Upgrade
|
Change in Accounts Receivable | 1,247 | 1,247 | -2,702 | -2,116 | -1,277 | -793.84 | Upgrade
|
Change in Inventory | 157.42 | 157.42 | -58.82 | -107.02 | -66.62 | -49.44 | Upgrade
|
Change in Accounts Payable | -1,633 | -1,633 | 891.85 | 1,162 | 796.25 | 746.26 | Upgrade
|
Change in Other Net Operating Assets | -40.89 | -40.89 | 102.14 | 133.14 | 45.88 | 16.24 | Upgrade
|
Operating Cash Flow | 1,035 | 1,231 | 1,948 | 2,088 | 1,523 | 661.4 | Upgrade
|
Operating Cash Flow Growth | -8.05% | -36.81% | -6.71% | 37.09% | 130.29% | 24.88% | Upgrade
|
Capital Expenditures | -502.46 | -714.75 | -840.54 | -952.42 | -550.65 | -274.92 | Upgrade
|
Sale of Property, Plant & Equipment | 21.55 | 18.94 | 20.37 | 73.23 | 10.61 | 4.36 | Upgrade
|
Cash Acquisitions | -4.3 | -6.7 | -22.09 | - | -19.96 | -12.64 | Upgrade
|
Divestitures | - | 218.03 | - | - | - | 38.91 | Upgrade
|
Investment in Securities | -26.98 | -150.29 | -8.52 | -131.98 | -74.38 | -62.36 | Upgrade
|
Other Investing Activities | 0.37 | 0.23 | 2.41 | 1.55 | 0.03 | 0.06 | Upgrade
|
Investing Cash Flow | -511.82 | -634.53 | -848.37 | -1,010 | -634.35 | -306.6 | Upgrade
|
Long-Term Debt Issued | - | 206.26 | 80 | - | 463.54 | 137.66 | Upgrade
|
Long-Term Debt Repaid | - | -330.43 | -295.51 | -187.63 | -616.32 | -269.75 | Upgrade
|
Net Debt Issued (Repaid) | 108.52 | -124.16 | -215.51 | -187.63 | -152.78 | -132.1 | Upgrade
|
Issuance of Common Stock | - | 41.76 | 36.63 | 342.13 | 46.15 | - | Upgrade
|
Repurchase of Common Stock | -89.99 | -89.99 | - | - | - | - | Upgrade
|
Common Dividends Paid | -417.77 | -839.33 | -609.52 | -169.98 | -91.92 | -87.56 | Upgrade
|
Other Financing Activities | -213.35 | -50.29 | -80.17 | -37.54 | -15.84 | -22.82 | Upgrade
|
Financing Cash Flow | -612.59 | -1,062 | -868.57 | -53.03 | -214.38 | -242.47 | Upgrade
|
Foreign Exchange Rate Adjustments | -15.58 | 7.39 | 38.95 | -11.46 | -3.76 | 0.75 | Upgrade
|
Net Cash Flow | -105.06 | -458.34 | 269.86 | 1,014 | 670.62 | 113.08 | Upgrade
|
Free Cash Flow | 532.47 | 516.07 | 1,107 | 1,136 | 972.45 | 386.47 | Upgrade
|
Free Cash Flow Growth | 55.70% | -53.39% | -2.49% | 16.77% | 151.62% | 110.78% | Upgrade
|
Free Cash Flow Margin | 6.78% | 6.04% | 7.16% | 9.51% | 11.80% | 7.33% | Upgrade
|
Free Cash Flow Per Share | 1.14 | 1.11 | 2.37 | 2.44 | 2.11 | 0.84 | Upgrade
|
Cash Income Tax Paid | 316.75 | 392.94 | 587.14 | 294.69 | 163.63 | 103.79 | Upgrade
|
Levered Free Cash Flow | 436.41 | 292.07 | 284.4 | 502.44 | 536.63 | 182.71 | Upgrade
|
Unlevered Free Cash Flow | 448.45 | 304.82 | 299.18 | 519.66 | 554.91 | 206.23 | Upgrade
|
Change in Net Working Capital | -240.28 | -122.55 | 1,622 | 897.59 | 404.58 | 118.63 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.